Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Alexion Pharmaceuticals, Inc.    ALXN   US0153511094

SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisionsForum 

Alexion Pharmaceuticals, Inc. : Alexion to Present at William Blair & Company 32nd Annual Growth Stock Conference

06/05/2012| 10:05am US/Eastern
Recommend:
0

Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced that Vikas Sinha, Chief Financial Officer of Alexion Pharmaceuticals, will present at the William Blair & Company 32nd Annual Growth Stock Conference in Chicago at 8:50 a.m. Central time (9:50 a.m. Eastern time) on Tuesday, June 12, 2012.

An audio webcast of Mr. Sinha's remarks will be available live. You can access the webcast at: www.alexionpharma.com. An archived version of the remarks will also be available through the Company's web site for a limited time following the conference.

[ALXN-G]

Alexion Pharmaceuticals, Inc.
Irving Adler
Sr. Director, Corporate Communications
203-271-8210
or
Alexion Pharmaceuticals, Inc.
Kim Diamond (Media)
Director, Corporate Communications
203-439-9600
or
Rx Communications
Rhonda Chiger (Investors)
917-322-2569


© Business Wire 2012
Recommend :
0
Partner Area
React to this article
 
Latest news on ALEXION PHARMACEUTICALS, I
05/08 ALEXION PHARMACEUTICALS, INC.: Alexion to Present at the BofA Merrill Lynch 201..
04/25 ALEXION PHARMACEUTICALS, INC.: Alexion Reports First Quarter 2013 Results
04/25 ALEXION PHARMACEUTICALS, INC.: Alexion Broadens and Strengthens its Executive L..
04/11 ALEXION PHARMACEUTICALS, INC.: Alexion Pharmaceuticals to Report First Quarter ..
03/14 ALEXION PHARMACEUTICALS, INC.: Alexion Joins the International Federation of Ki..
03/05 ALEXION PHARMACEUTICALS, INC.: Alexion to Present at the Barclays Global Health..
02/28 ALEXION PHARMACEUTICALS, INC.: Alexion Joins Eurordis, NORD and Patient Organiz..
02/25 ALEXION PHARMACEUTICALS, INC.: Alexion to Present at the Cowen and Company 33rd..
02/19 ALEXION PHARMACEUTICALS, INC.: StockCall Scrutinizes Alexion Pharma and Celgene..
02/14 ALEXION PHARMACEUTICALS, INC.: Alexion Reports Fourth Quarter and Full Year 201..
Advertisement
Chart
Duration : Period :
Alexion Pharmaceuticals, I Technical Analysis Chart | ALXN | US0153511094 | 4-Traders
Income Statement Evolution
Alexion Pharmaceuticals, I : Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF
Copyright © 2013 Surperformance. All rights reserved.